[1] |
Chen Chunxia,Chen Wan,Li Yaoxuan, et al. Hyperbaric oxygen protects against myocardial reperfusion injury via the inhibition of inflammation and the modulation of autophagy[J]. Oncotarget, 2017, 8(67): 111522-111534.
|
[2] |
Barančík M,Grešová L,Barteková M, et al. Nrf2 as a key player of redox regulation in cardiovascular diseases[J]. Physiological research, 2016, 65 Suppl 1:S1-S10.
|
[3] |
Yu Liming,Li Shu,Tang Xinlong, et al. Diallyl trisulfide ameliorates myocardial ischemia-reperfusion injury by reducing oxidative stress and endoplasmic reticulum stress-mediated apoptosis in type 1 diabetic rats: role of SIRT1 activation[J]. Apoptosis : an international journal on programmed cell death, 2017, 22(7):942-954.
|
[4] |
李冬梅,金笛,王琦,等.异丙酚2型糖尿病大鼠心肌缺血再灌注时细胞凋亡的影响[J]. 中华麻醉学杂志, 2014, 34(6):665-667.
|
[5] |
Cai Zhaobin,Shi Tingting,Zhuang Rangxiao, et al. Protective effect of N-acetylcysteine activated carbon release microcapsule on myocardial ischemia-reperfusion injury in rats[J]. Experimental and therapeutic medicine, 2018, 15(2):1809-1818.
|
[6] |
Raedschelders K,Ansley DM,Chen DD. The cellular and molecular origin of reactive oxygen species generation during myocardial ischemia and reperfusion[J]. Pharmacology& therapeutics, 2012, 133(2) :230-255.
|
[7] |
Wang Limin,Gao Pei,Zhang Mei, et al. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013[J]. Jama, 2017, 317(24): 2515-2523.
|
[8] |
Everett BM,Brooks MM,Vlachos HE, et al. Troponin and Cardiac Events in Stable Ischemic Heart Disease and Diabetes[J]. The New England journal of medicine, 2015, 373(7): 610-620.
|
[9] |
Alegria JR,Miller TD,Gibbons RJ, et al. Infarct size, ejection fraction, and mortality in diabetic patients with acute myocardial infarction treated with thrombolytic therapy[J]. American heart journal, 2007, 154(4):743-750.
|
[10] |
Marso SP,Miller T,Rutherford BD, et al. Comparison of myocardial reperfusion in patients undergoing percutaneous coronary intervention in ST-segment elevation acute myocardial infarction with versus without diabetes mellitus (from the EMERALD Trial) [J]. The American journal of cardiology, 2007, 100(2):206-210.
|
[11] |
Chu LM,Osipov RM,Robich MP, et al. Is hyperglycemia bad for the heart during acute ischemia?[J]. The Journal of thoracic and cardiovascular surgery, 2010, 140(6):1345-1352.
|
[12] |
陈衍恺.Sirtl调控自噬在I型糖尿病心肌缺血再灌注损伤中的作用机制研究[D]. 上海: 上海交通大学附属第六人民医院, 2015.
|
[13] |
胡静, 谷小雨, 孟炎, 等. 右美托咪定后处理对糖尿病大鼠心肌缺血再灌注损伤及炎症反应的影响[J]. 南方医科大学学报, 2017, 37(11):1506-1511.
|
[14] |
Gao Sumin,Yang Zhengchao,Shi Ruili, et al. Diabetes blocks the cardioprotective effects of sevoflurane postconditioning by impairing Nrf2/Brg1/HO-1 signaling[J]. European journal of pharmacology, 2016, 779:111-121.
|
[15] |
Wang Yan,Li Haobo,Huang Huansen, et al. Cardioprotection from emulsified isoflurane postconditioning is lost in rats with streptozotocin-induced diabetes due to the impairment of Brg1/Nrf2/STAT3 signalling[J]. Clinical science (London, England: 1979), 2016, 130(10): 801-812.
|
[16] |
Szkudelski T,Szkudelska K. Resveratrol and diabetes: from animal to human studies[J]. Biochimica et biophysica acta, 2015, 1852(6): 1145-1154.
|
[17] |
Cheng Liang,Jin Zhenxiao,Zhao Rong, et al. Resveratrol attenuates inflammation and oxidative stress induced by myocardial ischemia-reperfusion injury: role of Nrf2/ARE pathway[J]. International journal of clinical and experimental medicine, 2015, 8(7): 10420-10428.
|
[18] |
Dong Wusong,Yang Rui,Yang Jian, et al. Resveratrol pretreatment protects rat hearts from ischemia/reperfusion injury partly via a NALP3 inflammasome pathway[J]. International journal of clinical and experimental pathology, 2015, 8(8): 8731-8741.
|
[19] |
Yang Qiang,Wang Haichang,Liu Yi et al. Resveratrol Cardioprotection Against Myocardial Ischemia/Reperfusion Injury Involves Upregulation of Adiponectin Levels and Multimerization in Type 2 Diabetic Mice[J]. Journal of cardiovascular pharmacology, 2016, 68(4): 304-312.
|
[20] |
Huynh K,Kiriazis H,Du XJ, et al. Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice[J]. Free radical biology & medicine, 2013, 60:307-317.
|
[21] |
Khansari N,Shakiba Y,Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer[J]. Recent patents on inflammation & allergy drug discovery, 2009, 3(1): 73-80.
|
[22] |
Wang Dong,Zhang Xinjie,Li Defang, et al. Kaempferide Protects against Myocardial Ischemia/Reperfusion Injury through Activation of the PI3K/Akt/GSK-3beta Pathway[J]. Mediators of Inflammation 2017, Article ID 5278218, 11 pages.
|
[23] |
Di Paola R,Fusco R,Gugliandolo E, et al. The Antioxidant Activity of Pistachios Reduces Cardiac Tissue Injury of Acute Ischemia/Reperfusion (I/R) in Diabetic Streptozotocin (STZ)-Induced Hyperglycaemic Rats[J]. Frontiers in pharmacology, 2018, 9(51).
|
[24] |
Zhang Shouxin,Zhuang Lili,Liu Xiaoyan , et al. The role of Parkin protein in cardiac function and ventricular remodeling in myocardial infarction rats[J]. European review for medical and pharmacological sciences, 2018, 22(15): 5004-5013.
|
[25] |
Ključević N,Milat AM,Grga M, et al. White Wine Consumption Influences Inflammatory Phase of Repair After Myocardial Infarction in Rats[J]. Journal of cardiovascular pharmacology, 2017, 70(5): 293-299.
|
[26] |
You Shengban,Qian Jianchang,Sun Chuchu, et al. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress[J].Journal of Cellular and Molecular Medicine,2018, 22(3): 1931-1943.
|
[27] |
Gurusamy N,Lekli I,Mukherjee S, et al. Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway[J]. Cardiovascular research, 2010, 86(1): 103-112.
|
[28] |
黄晓雷,周晓云,杨剑愉,等.白藜芦醇对肠缺血再灌注诱发大鼠肺损伤及肺组织肥大细胞活化的影响[J]. 中华麻醉学杂志, 2016, 36(2):227-230.
|